Healthcare provider profile · identity verified

Christopher Michael Hunt, M.D.

Internal Medicine · SAN DIEGO, CA · NPI 1356384481

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	724	157
Levothyroxine Sodium	Levothyroxine Sodium	357	70
Quetiapine Fumarate	Quetiapine Fumarate	340	72
Pantoprazole Sodium	Pantoprazole Sodium	249	58
Trazodone Hcl	Trazodone Hcl	229	48
Amlodipine Besylate	Amlodipine Besylate	204	52
Potassium Chloride	Potassium Chloride	170	33
Divalproex Sodium	Divalproex Sodium	164	36
Olanzapine	Olanzapine	161	23
Tamsulosin Hcl	Tamsulosin Hcl	158	25
Eliquis	Apixaban	155	28
Furosemide	Furosemide	139	38
Mirtazapine	Mirtazapine	138	30
Lisinopril	Lisinopril	136	35
Gabapentin	Gabapentin	134	33
Losartan Potassium	Losartan Potassium	133	32
Escitalopram Oxalate	Escitalopram Oxalate	127	25
Donepezil Hcl	Donepezil Hcl	111	28
Omeprazole	Omeprazole	109	33
Metoprolol Succinate	Metoprolol Succinate	89	19
Metformin Hcl	Metformin Hcl	86	25
Simvastatin	Simvastatin	83	17
Rosuvastatin Calcium	Rosuvastatin Calcium	81	16
Memantine Hcl	Memantine Hcl	76	23
Sertraline Hcl	Sertraline Hcl	75	18
Lorazepam	Lorazepam	73	23
Tramadol Hcl	Tramadol Hcl	59	17
Clopidogrel	Clopidogrel Bisulfate	58	15
Famotidine	Famotidine	56	16
Alendronate Sodium	Alendronate Sodium	54	15
Atenolol	Atenolol	54	11
Duloxetine Hcl	Duloxetine Hcl	51	14
Finasteride	Finasteride	51	11
Fluoxetine Hcl	Fluoxetine Hcl	50	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	50	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	49	19
Albuterol Sulfate Hfa	Albuterol Sulfate	48	21
Ezetimibe	Ezetimibe	46	12
Oxybutynin Chloride Er	Oxybutynin Chloride	46	suppressed
Risperidone	Risperidone	45	suppressed
Clonazepam	Clonazepam	44	suppressed
Bupropion Xl	Bupropion Hcl	40	suppressed
Buspirone Hcl	Buspirone Hcl	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	21
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	37	31
Ketoconazole	Ketoconazole	35	22
Carvedilol	Carvedilol	33	suppressed
Jardiance	Empagliflozin	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Naproxen	Naproxen	32	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Aripiprazole	Aripiprazole	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Levetiracetam	Levetiracetam	28	suppressed
Divalproex Sodium Er	Divalproex Sodium	27	suppressed
Gemtesa	Vibegron	27	suppressed
Azithromycin	Azithromycin	26	20
Carbamazepine	Carbamazepine	26	suppressed
Glipizide	Glipizide	26	suppressed
Temazepam	Temazepam	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	21
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Propranolol Hcl	Propranolol Hcl	24	suppressed
Prednisone	Prednisone	23	11
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Baclofen	Baclofen	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Lactulose	Lactulose	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	15
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Icosapent Ethyl	Icosapent Ethyl	14	suppressed
Klor-Con 10	Potassium Chloride	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Loperamide	Loperamide Hcl	14	13
Nystatin	Nystatin	14	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	14	11
Spironolactone	Spironolactone	14	suppressed
Colchicine	Colchicine	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Levofloxacin	Levofloxacin	13	suppressed
Ondansetron Odt	Ondansetron	13	11
Phenobarbital	Phenobarbital	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Rexulti	Brexpiprazole	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Gabapentin Er	Gabapentin	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error